Translational Research
Volume 152, Issue 2 , Pages 59-66 , August 2008

In vitro studies of amikacin-loaded human carrier erythrocytes

Received 3 March 2008 ,Revised 28 May 2008 ,Accepted 29 May 2008.

References 

  1. Ihler GM, Glew RH, Schunure FW. Enzyme loading of erythrocytes. Proc Nat Acad Sci USA. 1973;70:2663–2666
  2. Dale G, Villacorte D, Beutler E. High-yield entrapment of proteins into erythrocytes. Biochem Med. 1977;18:220–225
  3. DeLoach JR, Ihler G. A dialysis procedure for loading erythrocytes with enzymes and lipids. Biochim Biophys Acta. 1977;496:136–145
  4. Gutiérrez Millán C, Sayalero Marinero ML, Zarzuelo Castañeda A, Lanao JM. Drug, enzyme and peptide delivery using erythrocytes as carriers. J Control Release. 2004;95:27–49
  5. Rossi L, Serafini S, Pierigé F, et al. Erythrocyte-based drug delivery. Expert Opinion Drug Deliv. 2005;2:311–322
  6. Hamidi M, Zarrin A, Foroozesh M, Mahammadi-Samani S. Applications of carrier erythrocytes in delivery of biopharmaceuticals. J Control Release. 2007;118:145–160
  7. Hamidi M, Zarei N, Zarrin AH, Mahammadi-Samani S. Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery. Int J Pharm. 2007;338:70–78
  8. Zocchi E, Tonetti M, Polvani C, Guida L, Benatti U, DeFlora A. Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastitic model. Proc Natl Acad Sci U S A. 1989;86:2040–2044
  9. Gasparini A, Chiarantini L, Kirch H, DeLoach JR. In vitro targeting of doxorubicin loaded canine erythrocytes to cytotoxic T-lymphocytes (CTLL). In:  Magnani M,  DeLoach JR editor. Advances in experimental medicine and biology, vol. 326, The use of resealed erythrocytes as carriers and bioreactors. New York: Plenum Press; 1992;p. 291–297
  10. Bax BE, Bain MD, Talbot PJ, Parker-Williams EJ, Chalmers RA. Survival of carrier erythrocytes in vivo. Cli Sci. 1999;96:171–178
  11. Bax BE, Bain MD, Fairbanks LD, Simmonsd AH, Webster AD, Chalmers RA. Carrier erythrocyte entrapped adenosine deaminase therapy in adenosine deaminase deficiency. Adv Exp Med Biol. 2000;486:47–50
  12. Bax BE, Bain MD, Fairbanks LD, Webster AD, Chalmers AD. In vitro and in vivo studies of human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase. Br J Haematol. 2000;109:549–554
  13. Hamidi M, Tajerzadeh H. Carrier erythrocytes: an overview. Drug Deliver. 2003;10:9–20
  14. Murray AM, Pearson IF, Fairbanks LD, Chalmers RA, Bain MD, Bax BE. The mouse immune response to carrier erythrocyte entrapped antigens. Vaccine. 2006;24:6129–6139
  15. DeLoach JR. Dialysis method for entrapment of proteins into resealed red blood cells. In:  Green R,  Widder KJ editor. Methods in enzymology. vol. 149:San Diego, Calif: Academic Press; 1987;p. 235–242
  16. Dale G. High-efficiency entrapment of enzymes in resealed red cell ghosts by dialysis. In:  Green R,  Widder KJ editor. Methods in enzymology. vol. 149:San Diego, Calif: Academic Press; 1987;p. 229–234
  17. Álvarez FJ, Jordán JA, Herráez A, Díez JC, Tejedor MC. Hypotonically loaded rat erythrocytes deliver encapsulated substances into peritoneal macrophages. J Biochem. 1998;123:233–239
  18. Gutiérrez Millán C, Zarzuelo Castañeda A, Sayalero Marinero ML, Lanao JM. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. Blood Cells Mol Dis. 2004;33:132–140
  19. Belyi IF. Actin machinery of phagocytic cells: universal target for bacterial attack. Micros Res Tech. 2002;57:432–440
  20. Bermúdez LE. Immunobiology of mycobacterium avium infection. Eur J Clin Microbiol Infect Dis. 1994;13:1000–1006
  21. Fraternale A, Casabianca C, Orlandi A, et al. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in murine AIDS model. Antivir Res. 2002;56:263–272
  22. Cervasi B, Paiardini M, Serafini S, et al. Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy. J Virol. 2006;80:10335–10345
  23. Rossi L, Franchetti P, Pierigé F, et al. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir. J Antimicrob Chemother. 2007;59:666–675
  24. Gutiérrez Millán C, Zarzuelo Castañeda A, González López F, Sayalero Marinero ML, Lanao JM. Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes. Drug Deliv. 2005;12:409–416
  25. Gutiérrez Millán C, Zarzuelo Castañeda A, González López F, Sayalero Marinero ML, Lanao JM. Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes. J Antimicrob Chemother. 2008;61:375–381
  26. Dacie J. The hemolytic anemias (congenital and acquired part I: the congenital anemias). New York: Grune and Stratton; 1960;
  27. Dacie JV, Lewis SM. Practical haematology. New York: Churchill-Livingston; 1975;
  28. Santos B, Sayalero ML, Zarzuelo A, Lanao JM. Determination of amikacin in biological tissues by HPLC. J Liq Chrom Rel Technol. 2002;25:463–473
  29. Weitzman EA. Analyzing qualitative data with computer software. Health Serv Res. 1999;34:1241–1263
  30. Lynch WE, Sartiano GP, Ghaffar A. Erythrocytes as carriers of chemotherapeutic agents for targeting the reticuloendothelial system. Am J Hematol. 1980;9:249–259
  31. Eichler HG, Rameis H, Bauer K, Korn A, Bacher S, Gasic S. Survival of Gentamicin-loaded carrier erythrocytes in healthy human volunteers. Eur J Clin Invest. 1986;16:39–42

 Supported by the National Research and Development Plan (Projects SAF 2001-0740 and PI 06152) from the Spanish Government and by a discretionary grant (to B.E.B.).

PII: S1931-5244(08)00153-9

doi: 10.1016/j.trsl.2008.05.008

Translational Research
Volume 152, Issue 2 , Pages 59-66 , August 2008

Article Tools

* Image Usage & Resolution